198 related articles for article (PubMed ID: 19226619)
1. Peptidic modulators of protein-protein interactions: progress and challenges in computational design.
Rubinstein M; Niv MY
Biopolymers; 2009 Jul; 91(7):505-13. PubMed ID: 19226619
[TBL] [Abstract][Full Text] [Related]
2. Protein-protein interactions as targets for antiviral chemotherapy.
Loregian A; Marsden HS; Palù G
Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
[TBL] [Abstract][Full Text] [Related]
3. Specific modulation of protein kinase activity via small peptides.
Costa-Junior HM; Suetsugu MJ; Krieger JE; Schechtman D
Regul Pept; 2009 Feb; 153(1-3):11-8. PubMed ID: 19135095
[TBL] [Abstract][Full Text] [Related]
4. Computational design of peptide ligands.
Vanhee P; van der Sloot AM; Verschueren E; Serrano L; Rousseau F; Schymkowitz J
Trends Biotechnol; 2011 May; 29(5):231-9. PubMed ID: 21316780
[TBL] [Abstract][Full Text] [Related]
5. Emerging classes of protein-protein interaction inhibitors and new tools for their development.
Pagliaro L; Felding J; Audouze K; Nielsen SJ; Terry RB; Krog-Jensen C; Butcher S
Curr Opin Chem Biol; 2004 Aug; 8(4):442-9. PubMed ID: 15288255
[TBL] [Abstract][Full Text] [Related]
6. Strategies for targeting protein-protein interactions with synthetic agents.
Yin H; Hamilton AD
Angew Chem Int Ed Engl; 2005 Jul; 44(27):4130-63. PubMed ID: 15954154
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic discovery of novel bioactive peptides.
Edwards RJ; Moran N; Devocelle M; Kiernan A; Meade G; Signac W; Foy M; Park SD; Dunne E; Kenny D; Shields DC
Nat Chem Biol; 2007 Feb; 3(2):108-12. PubMed ID: 17220901
[TBL] [Abstract][Full Text] [Related]
8. Modulation of biomolecular interactions with complex-binding small molecules.
Cai Z; Greene MI; Berezov A
Methods; 2008 Sep; 46(1):39-46. PubMed ID: 18571508
[TBL] [Abstract][Full Text] [Related]
9. Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates.
Kontijevskis A; Petrovska R; Yahorava S; Komorowski J; Wikberg JE
Bioorg Med Chem; 2009 Jul; 17(14):5229-37. PubMed ID: 19539482
[TBL] [Abstract][Full Text] [Related]
10. Computational approaches to therapeutic peptide discovery.
Kliger Y
Biopolymers; 2010; 94(6):701-10. PubMed ID: 20564036
[TBL] [Abstract][Full Text] [Related]
11. Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
Watt PM
Nat Biotechnol; 2006 Feb; 24(2):177-83. PubMed ID: 16465163
[TBL] [Abstract][Full Text] [Related]
12. Rational drug design.
Mandal S; Moudgil M; Mandal SK
Eur J Pharmacol; 2009 Dec; 625(1-3):90-100. PubMed ID: 19835861
[TBL] [Abstract][Full Text] [Related]
13. iPEP: peptides designed and selected for interfering with protein interaction and function.
Mason JM; M Müller K; Arndt KM
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1442-7. PubMed ID: 19021572
[TBL] [Abstract][Full Text] [Related]
14. Disruption of protein-protein interactions: towards new targets for chemotherapy.
Loregian A; Palù G
J Cell Physiol; 2005 Sep; 204(3):750-62. PubMed ID: 15880642
[TBL] [Abstract][Full Text] [Related]
15. The design, structures and therapeutic potential of protein epitope mimetics.
Robinson JA; Demarco S; Gombert F; Moehle K; Obrecht D
Drug Discov Today; 2008 Nov; 13(21-22):944-51. PubMed ID: 18725320
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial and computational approaches in structure-based drug design.
Kubinyi H
Curr Opin Drug Discov Devel; 1998 Jul; 1(1):16-27. PubMed ID: 19649785
[TBL] [Abstract][Full Text] [Related]
17. Managing protein flexibility in docking and its applications.
B-Rao C; Subramanian J; Sharma SD
Drug Discov Today; 2009 Apr; 14(7-8):394-400. PubMed ID: 19185058
[TBL] [Abstract][Full Text] [Related]
18. The use of peptides to reconstruct conformational determinants; a brief review.
Meloen RH; Amerongen AV; Hage-Van Noort M; Langedijk JP; Posthumus WP; Puyk WC; Plasman H; Lenstra JA; Langeveld JP
Ann Biol Clin (Paris); 1991; 49(4):231-41. PubMed ID: 1928839
[TBL] [Abstract][Full Text] [Related]
19. Protein-protein interactions: a simple strategy to identify binding sites and peptide antagonists.
Sandomenico A; Monti SM; Sabatella M; De Capua A; Tornatore L; Doti N; Viparelli F; Dathan NA; Pedone C; Ruvo M; Marasco D
Chem Biol Drug Des; 2009 May; 73(5):483-93. PubMed ID: 19366357
[TBL] [Abstract][Full Text] [Related]
20. Advances in the prediction of protein-peptide binding affinities: implications for peptide-based drug discovery.
Audie J; Swanson J
Chem Biol Drug Des; 2013 Jan; 81(1):50-60. PubMed ID: 23066895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]